Ellicott City, MD, United States of America

Wenbin Dang


Average Co-Inventor Count = 2.3

ph-index = 7

Forward Citations = 201(Granted Patents)


Location History:

  • Arlington, MA (US) (2001)
  • Baltimore, MD (US) (2001 - 2003)
  • Ellicot City, MD (US) (2003)
  • Ellicott City, MD (US) (2000 - 2004)
  • Belle Mead, NJ (US) (2003 - 2006)

Company Filing History:


Years Active: 2000-2006

Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Wenbin Dang

Introduction

Wenbin Dang is a prominent inventor based in Ellicott City, MD, known for his significant contributions to the field of biomedical engineering. With a total of 12 patents to his name, he has made remarkable advancements in the treatment of solid tumors and the development of biodegradable polymer compositions.

Latest Patents

Among his latest patents are innovative methods and compositions for treating solid tumors. He has developed a biodegradable polymer composition that includes poly(cycloaliphatic phosphoester) compounds. These advancements are crucial for creating effective and environmentally friendly medical solutions.

Career Highlights

Wenbin Dang has had a notable career, including his work at Guilford Pharmaceuticals, Inc. His expertise in biomedical engineering has allowed him to contribute to various projects that aim to improve patient outcomes through innovative treatments.

Collaborations

Throughout his career, Wenbin has collaborated with esteemed colleagues such as Hai-Quan Mao and Kam W Leong. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking technologies.

Conclusion

Wenbin Dang's contributions to the field of biomedical engineering through his patents and collaborations highlight his commitment to innovation and improving healthcare solutions. His work continues to inspire future advancements in the treatment of solid tumors and biodegradable materials.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…